Home > Publications database > Expression of Bovine Meat and Milk Factor in Hepatocellular Carcinoma and Colorectal Liver Metastasis Patients. > print

001     303254
005     20250802114338.0
024 7 _ |a 10.1002/jmv.70507
|2 doi
024 7 _ |a pmid:40741925
|2 pmid
024 7 _ |a 0146-6615
|2 ISSN
024 7 _ |a 1096-9071
|2 ISSN
037 _ _ |a DKFZ-2025-01599
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Siqin, Sumen
|0 P:(DE-He78)a0206cc58a953ec87e0baa6eaaa9863c
|b 0
|e First author
|u dkfz
245 _ _ |a Expression of Bovine Meat and Milk Factor in Hepatocellular Carcinoma and Colorectal Liver Metastasis Patients.
260 _ _ |a Bognor Regis [u.a.]
|c 2025
|b Wiley
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1754055244_19096
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:D460#LA:D460#
520 _ _ |a Bovine meat and milk factors (BMMFs) are plasmid-like DNA molecules isolated from cow's milk, meat, and human cancer tissues proposed to contribute to the development of specific types of cancer including colorectal cancer (CRC) and breast cancer based on chronic inflammation-associated indirect carcinogenesis. Chronic necro-inflammation of the liver poses a strong risk factor for the induction of hepatocellular carcinoma (HCC), which is associated with high intake of meat. Whether BMMFs contribute to HCC carcinogenesis or the development of colorectal liver metastasis (CRLM) remains unknown. Therefore, in this study, the presence of BMMFs was assessed in the liver of patients with viral and nonviral hepatitis-related HCC (n = 25), CRLM (14) and in healthy liver tissue from autopsy specimens (18) using monoclonal antibodies against the conserved BMMF Rep protein for immunohistochemistry, immunofluorescence detection, and immunoblotting. Rep was expressed in all tumor-distant and peritumor tissue specimens of HCC and CRLM patients and associated with CD68+ macrophages around portal triads. The number of Rep+CD68+cells was increased in HCC and CRLM patients compared to healthy liver tissue, which may indicate a link between BMMFs and tumor-associated chronic inflammation in the liver. Exclusively in viral hepatitis-linked HCC, Rep expression was also detected in the tumor. In addition, specifically in the liver of healthy individuals, we observed a well-defined gradient Rep expression in hepatocytes around the central veins. Altogether, these observations may indicate that the presence of BMMFs in the liver is associated with chronic inflammation and may represent a novel risk factor or surrogate marker for liver cancer.
536 _ _ |a 314 - Immunologie und Krebs (POF4-314)
|0 G:(DE-HGF)POF4-314
|c POF4-314
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a bovine meat and milk factors (BMMFs)
|2 Other
650 _ 7 |a chronic inflammation
|2 Other
650 _ 7 |a chronic viral hepatitis
|2 Other
650 _ 7 |a colorectal liver metastasis
|2 Other
650 _ 7 |a hepatocellular carcinoma
|2 Other
650 _ 7 |a infectious indirect carcinogenesis
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Carcinoma, Hepatocellular: pathology
|2 MeSH
650 _ 2 |a Liver Neoplasms: pathology
|2 MeSH
650 _ 2 |a Liver Neoplasms: secondary
|2 MeSH
650 _ 2 |a Colorectal Neoplasms: pathology
|2 MeSH
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Cattle
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Immunohistochemistry
|2 MeSH
650 _ 2 |a Liver: pathology
|2 MeSH
650 _ 2 |a Adult
|2 MeSH
650 _ 2 |a Milk: chemistry
|2 MeSH
700 1 _ |a Rahbari, Mohammad
|0 P:(DE-He78)8757fd490dcfe2d6c4b1c2b126262468
|b 1
|u dkfz
700 1 _ |a Ernst, Claudia
|0 P:(DE-He78)e228057961cd499cd6acd0ce04076f77
|b 2
|u dkfz
700 1 _ |a Grewe, Imke
|0 P:(DE-He78)1c29c4dec56c7acb89b190e1c2d3f49c
|b 3
|u dkfz
700 1 _ |a Gunst, Karin
|0 P:(DE-He78)75f6c58dfab869f5993d696577e466dc
|b 4
|u dkfz
700 1 _ |a Neßling, Michelle
|0 P:(DE-He78)f2b6a344bfd285e1d62daa3886ffb5fc
|b 5
|u dkfz
700 1 _ |a Kaden, Sylvia
|0 P:(DE-He78)6093fbefe5b51f07e37146565925d681
|b 6
|u dkfz
700 1 _ |a Richter, Karsten
|0 P:(DE-He78)027fe772631b4a2d7a45c439cdd75ff2
|b 7
|u dkfz
700 1 _ |a Häfele, Lisa
|0 P:(DE-He78)e93034f3a91875bac56c55c8e9ed124d
|b 8
|u dkfz
700 1 _ |a Feuerbach, Lars
|0 P:(DE-He78)75e2afb3ea0812786cc551c10679b67d
|b 9
|u dkfz
700 1 _ |a Krunic, Damir
|0 P:(DE-He78)2214defe87d04a849413e5eed47c415e
|b 10
|u dkfz
700 1 _ |a Tessmer, Claudia
|0 P:(DE-He78)44a33c775d0e27db79f8fd9e97a99e0a
|b 11
|u dkfz
700 1 _ |a Hofmann, Ilse
|0 P:(DE-He78)0c4543046185361a644540fee0dad8b1
|b 12
|u dkfz
700 1 _ |a Birgin, Emrullah
|b 13
700 1 _ |a Brobeil, Alexander
|b 14
700 1 _ |a Rahbari, Nuh
|b 15
700 1 _ |a Heikenwälder, Mathias
|0 P:(DE-He78)66ed2d4ec9bc11d29b87ac006adf85e5
|b 16
|u dkfz
700 1 _ |a Bund, Timo
|0 P:(DE-He78)42946c81b039c802769d91e486a4d5fb
|b 17
|e Last author
|u dkfz
773 _ _ |a 10.1002/jmv.70507
|g Vol. 97, no. 8, p. e70507
|0 PERI:(DE-600)1475090-9
|n 8
|p e70507
|t Journal of medical virology
|v 97
|y 2025
|x 0146-6615
909 C O |o oai:inrepo02.dkfz.de:303254
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)a0206cc58a953ec87e0baa6eaaa9863c
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)8757fd490dcfe2d6c4b1c2b126262468
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)e228057961cd499cd6acd0ce04076f77
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)1c29c4dec56c7acb89b190e1c2d3f49c
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)75f6c58dfab869f5993d696577e466dc
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)f2b6a344bfd285e1d62daa3886ffb5fc
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)6093fbefe5b51f07e37146565925d681
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)027fe772631b4a2d7a45c439cdd75ff2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)e93034f3a91875bac56c55c8e9ed124d
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)75e2afb3ea0812786cc551c10679b67d
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)2214defe87d04a849413e5eed47c415e
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)44a33c775d0e27db79f8fd9e97a99e0a
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 12
|6 P:(DE-He78)0c4543046185361a644540fee0dad8b1
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 16
|6 P:(DE-He78)66ed2d4ec9bc11d29b87ac006adf85e5
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 17
|6 P:(DE-He78)42946c81b039c802769d91e486a4d5fb
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-314
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Immunologie und Krebs
|x 0
914 1 _ |y 2025
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2025-01-02
|w ger
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2025-01-02
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J MED VIROL : 2022
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2025-01-02
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-02
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b J MED VIROL : 2022
|d 2025-01-02
920 2 _ |0 I:(DE-He78)D460-20160331
|k D460
|l Arbeitsgruppe Episomal-Persistierende DNA in Krebs- und chron. Erkrankungen
|x 0
920 1 _ |0 I:(DE-He78)D460-20160331
|k D460
|l Arbeitsgruppe Episomal-Persistierende DNA in Krebs- und chron. Erkrankungen
|x 0
920 1 _ |0 I:(DE-He78)D440-20160331
|k D440
|l Chronische Entzündung und Krebs
|x 1
920 1 _ |0 I:(DE-He78)W230-20160331
|k W230
|l Elektronenmikroskopie
|x 2
920 1 _ |0 I:(DE-He78)B330-20160331
|k B330
|l Angewandte Bioinformatik
|x 3
920 1 _ |0 I:(DE-He78)W210-20160331
|k W210
|l Lichtmikroskopie
|x 4
920 1 _ |0 I:(DE-He78)W170-20160331
|k W170
|l Monoklonale Antikörper
|x 5
920 0 _ |0 I:(DE-He78)D460-20160331
|k D460
|l Arbeitsgruppe Episomal-Persistierende DNA in Krebs- und chron. Erkrankungen
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)D460-20160331
980 _ _ |a I:(DE-He78)D440-20160331
980 _ _ |a I:(DE-He78)W230-20160331
980 _ _ |a I:(DE-He78)B330-20160331
980 _ _ |a I:(DE-He78)W210-20160331
980 _ _ |a I:(DE-He78)W170-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21